Inventor · disambiguated record
Guillaume Stewart-Jones
Also filed as: STEWART-JONES GUILLAUME
17 granted patents·23 pending applications·53 citations·filing 2014–2025
92Inventor score
Files withUS HEALTH17MODERNATX INC14THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC4MODERNA TX INC1STEWART JONES GUILLAUME1
Top patents by PatentIndex Score
40 records- 0194US10017543B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2014·Granted Jul 10, 2018·26 cites·58 claims
- 0293US11878998B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2021·Granted Jan 23, 2024·2 cites·27 claims
- 0393US10400015B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2015·Granted Sep 3, 2019·10 cites·51 claims
- 0490US11459360B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2019·Granted Oct 4, 2022·4 cites·30 claims
- 0590US10420834B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2015·Granted Sep 24, 2019·4 cites·53 claims
- 0689US2025368690A1Prefusion rsv f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 0788US12435113B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2023·Granted Oct 7, 2025·0 cites·27 claims
- 0888US12233124B2Recombinant metapneumovirus f proteins and their useUS HEALTH·Filed 2023·Granted Feb 25, 2025·0 cites·35 claims
- 0987US12275758B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2024·Granted Apr 15, 2025·0 cites·29 claims
- 1087US11981707B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2023·Granted May 14, 2024·0 cites·25 claims
- 1187US11130785B2Prefusion RSV F proteins and their useUS HEALTH·Filed 2018·Granted Sep 28, 2021·2 cites·24 claims
- 1286US11890339B2Nipah virus immunogens and their useUS HEALTH·Filed 2019·Granted Feb 6, 2024·2 cites·35 claims
- 1386US11174292B2Substitutions-modified prefusion RSV F proteins and their useUS HEALTH·Filed 2017·Granted Nov 16, 2021·2 cites·35 claims
- 1481US11078239B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2017·Granted Aug 3, 2021·1 cites·24 claims
- 1580US12145968B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2022·Granted Nov 19, 2024·0 cites·13 claims
- 1677US11845778B2Prefusion PIV F immunogens and their useUS HEALTH·Filed 2021·Granted Dec 19, 2023·0 cites·23 claims
- 1777US11786591B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2021·Granted Oct 17, 2023·0 cites·36 claims
- 1876US11027007B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2019·Granted Jun 8, 2021·0 cites·37 claims
- 1976US2024197858A1Nipah virus immunogens and their useTHE U S A AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICE·Filed 2024·Application pending·0 cites
- 2075US2022002351A1Prefusion rsv f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2021·Application pending·0 cites
- 2175US2025387464A1Recombinant metapneumovirus f proteins and their useTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 2274US2025367278A1Variant strain-based coronavirus vaccinesMODERNATX INC·Filed 2025·Application pending·0 cites
- 2370US2025388627A1Prefusion rsv f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2025·Application pending·0 cites
- 2466US2024139309A1Variant strain-based coronavirus vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 2564US2024382581A1Pan-human coronavirus vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 2663US2024285754A1Mrna vaccines encoding flexible coronavirus spike proteinsMODERNATX INC·Filed 2022·Application pending·0 cites
- 2761US2024293534A1Coronavirus glycosylation variant vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 2861US2024358819A1Pan-human coronavirus domain vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 2961US2021228707A1Coronavirus rna vaccinesMODERNATX INC·Filed 2020·Application pending·0 cites
- 3058US2023355743A1Multi-proline-substituted coronavirus spike protein vaccinesSTEWART JONES GUILLAUME·Filed 2021·Application pending·0 cites
- 3156US2024299531A1Therapeutic use of sars-cov-2 mrna domain vaccinesMODERNA TX INC·Filed 2022·Application pending·0 cites
- 3255US2024207392A1Epstein-barr virus mrna vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 3355US2024100151A1Variant strain-based coronavirus vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 3454US2023346914A1Sars-cov-2 mrna domain vaccinesMODERNATX INC·Filed 2021·Application pending·0 cites
- 3553US2024216500A1Respiratory virus combination vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 3652US2023338506A1Respiratory virus immunizing compositionsMODERNATX INC·Filed 2021·Application pending·0 cites
- 3752US2023174587A1Recombinant human metapneumovirus f proteins and their useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2021·Application pending·0 cites
- 3851US2023053555A1Mumps and measles virus immunogens and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 3951US2024226277A1Influenza-coronavirus combination vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 4048US2023108894A1Coronavirus rna vaccinesMODERNATX INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guillaume Stewart-Jones files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →